Psychiatry and Neurology, Neurology · Oklahoma City, OK
NPI
1962542225
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
825 NE 10th St Ste 5b
Oklahoma City, OK, 73104
Phone (405) 271-3635
Groups this clinician bills Medicare through
Medicare paid, 2024
$209K
13,443 services
Medicare patients, 2024
351
Average age 76
Drug cost, 2024
$2.2M
3,413 prescriptions
Company payments, 2025
$21K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mariana G Varga was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,302 times for 22 patients. In total Mariana G Varga billed 13,443 services in 15 codes, and Medicare paid $209K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,302 | 22 | $4.96 | $46K |
| 95984 Electrical Nerve Conductivity | Office | 951 | 61 | $34.23 | $33K |
| 99215 Office E&M - Established | Office | 471 | 227 | $137.72 | $65K |
| 95983 Electrical Nerve Conductivity | Office | 162 | 61 | $37.50 | $6,075 |
| 99205 Office E&M - New | Office | 111 | 111 | $167.92 | $19K |
| 95970 Electrical Nerve Conductivity | Office | 101 | 58 | $12.95 | $1,308 |
| 99214 Office E&M - Established | Office | 70 | 60 | $80.91 | $5,664 |
| 64616 Musculoskeletal | Office | 64 | 23 | $130.58 | $8,357 |
| 95874 Musculoskeletal | Office | 60 | 21 | $59.92 | $3,595 |
| 95984 Electrical Nerve Conductivity | Facility | 51 | 12 | $35.57 | $1,814 |
| 95962 Neurologic | Facility | 34 | 12 | $141.12 | $4,798 |
| 95961 Neurologic | Facility | 17 | 12 | $132.19 | $2,247 |
| 95983 Electrical Nerve Conductivity | Facility | 17 | 12 | $40.58 | $690 |
By year: 2022 $229K for 16,515 services; 2023 $203K for 15,284 services; 2024 $209K for 13,443 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mariana G Varga prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 953 prescriptions and refills. In total Mariana G Varga wrote 3,413 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 953 | 2,187 | 258 | $37K |
| Rasagiline Mesylate Generic | 543 | 1,319 | 142 | $92K |
| Rytary Carbidopa/Levodopa | 368 | 720 | 82 | $208K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 358 | 880 | 105 | $9,659 |
| Primidone Generic | 244 | 605 | 73 | $6,546 |
| Clonazepam Generic | 175 | 341 | 52 | $1,606 |
| Nuplazid Pimavanserin Tartrate | 88 | 106 | 13 | $526K |
| Citalopram Hbr Citalopram Hydrobromide | 57 | 113 | 13 | $386 |
| Austedo Deutetrabenazine | 51 | 55 | Under 11 | $322K |
| Botox Onabotulinumtoxina | 51 | 143 | 24 | $76K |
| Gocovri Amantadine Hcl | 50 | 70 | Under 11 | $156K |
| Donepezil Hcl Generic | 46 | 100 | 14 | $522 |
| Gabapentin Generic | 45 | 86 | 11 | $1,323 |
| Droxidopa Generic | 37 | 56 | Under 11 | $92K |
| Ongentys Opicapone | 32 | 80 | Under 11 | $49K |
Brand drugs: 919 claims; generic drugs: 2,494 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mariana G Varga $21K ($21K in general payments such as food, travel and fees) from 14 companies. The largest payer was MDD US Operations, LLC with $18K.
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 21 | $18K |
| Medtronic, Inc. MDT | 36 | $1,615 |
| Boston Scientific Corporation BSX | 13 | $191 |
| MicroTransponder, Inc. | 1 | $157 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $156 |
| Argenx US, Inc. ARGX | 1 | $116 |
| Biogen, Inc. BIIB | 1 | $112 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $89.94 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $58.39 |
| Abbvie Inc. ABBV | 3 | $52.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.